Le Lézard
Classified in: Health
Subjects: SVY, LEG, AVO

AUDICUS, ONLINE HEARING HEALTH COMPANY FOUNDED ON THE MISSION OF PROVIDING AFFORDABLE AND ACCESSIBLE HEARING AIDS, SAYS FDA RULE WILL CONTINUE TO FUEL INNOVATION IN THE SPACE


NEW YORK, Aug. 17, 2022 /PRNewswire/ -- Audicus, the long-time provider and premier name in affordable, fully-customizable online hearing aids, celebrates the final FDA rule issued on Tuesday. The long-awaited rule, stemming from 2017 congressional legislation, establishes a new category of over-the-counter (OTC) hearing aids and will enable consumers with hearing loss to purchase hearing aids without the need for a prescription from an audiologist.

"It's no secret the hearing industry has been in need of a shakeup for a long time,"  Patrick Freuler, CEO of Audicus.

"It's no secret the hearing industry has been in need of a shakeup for a long time," said Patrick Freuler, Founder and CEO of Audicus. "We set out on the mission of making hearing care affordable and accessible for all over a decade ago. In that time, we've been able to save customers millions of dollars on hearing care, while helping so many people live more empowered, connected, and healthier lives. Over and over again, we've seen far too many people avoid addressing their hearing health due to high costs and lack of access, and we're excited this FDA rule will allow us to continue to provide even more affordable hearing solutions to the millions of Americans in need."

Nearly 30 million Americans could benefit from the use of hearing aids, but in a February 2022 survey, Audicus found high costs were the main prohibitor of addressing hearing issues, with about 40% of respondents noting that costs were too high. These high costs lead to many years of unaddressed hearing loss, with the average hearing aid user waiting 10 years before seeking help, according to a Johns Hopkins study that tied hearing loss to the risk of developing dementia.

"We're excited to keep breaking down these barriers and to continue our record of innovation in the space," Freuler continued. "We were the first to offer an end-to-end online customizable hearing solution, and we've continued to innovate new ways to make hearing care even more affordable. We just launched a new subscription product that lets users access advanced hearing aid technology and on-demand support for only $99/month, giving our consumers more options when it comes to easy and affordable hearing solutions."

The final FDA rule will be effective in the Fall.

About Audicus

Audicus offers award-winning, affordable hearing aids online, at a fraction of the cost of traditional audiologists. Through its innovative business model, Audicus has enabled consumers to save more than $50 million since 2012, and has helped hundreds of thousands lead more connected and empowered lives. Audicus was also the first to introduce a hearing aid subscription to members, with fully customizable hearing aids starting at $99 per month.

For more information on Audicus, visit www.audicus.com.

Media Contact:

Chelsey Seabrook
[email protected]

SOURCE AUDICUS


These press releases may also interest you

at 05:50
CN Bio, a leading provider of single- and multi-organ microphysiological systems, today announced it has raised a $21 million investment in the first close of its Series B fundraising round. The funding has been secured from several new investors;...

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:05
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...



News published on and distributed by: